Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2020 filings

All 25 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2020, sourced directly from the official regulator.

25 Filings
2020 Period
2020 filings (25)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-12-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-12-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-12-04 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-13 Korean
기타경영사항(특허권취득)(자율공시)(유체 샘플로부터 세포 외 소포체를 고농축하는 크기 기반 분리법)
Regulatory Filings
2020-10-22 Korean
기타경영사항(특허권취득)(자율공시)(물질 P를 포함하는 난치성 궤양 치료용 조성물)
Regulatory Filings
2020-09-17 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
기타경영사항(자율공시)(국책과제 선정(보건복지부 첨단의료기술개발))
Regulatory Filings
2020-04-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-30 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-20 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-20 Korean
주주총회소집결의
AGM Information
2020-03-12 Korean
주주총회집중일개최사유신고
Regulatory Filings
2020-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-12 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2019
2020-02-07 Korean
기타경영사항(특허권취득)(자율공시)(구슬형 연골세포 치료제의 제조방법)
Regulatory Filings
2020-02-04 Korean
대표이사변경
Board/Management Information
2020-01-14 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update
2020-01-07 Korean